Country | Clinical service | Indicator | N | Direct clinical service | Condoms and lubricants | Indirect | Total unit cost | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | UC | 95% CI | UC | 95% CI | UC | 95% CI | UC | 95% CI |
Kenya | PEP | Treated | 25 | 95 | 76–114 | 5 | 1–9 | 356 | 295–416 | 456 | 350–562 |
PREP | On PrEPa | 30 | 127 | 90–165 | 51 | 27–74 | 456 | 350–562 | 635 | 484–785 | |
HTS | Tested | 30 | 5 | 4–6 | 5 | 3–7 | 14 | 12–16 | 24 | 21–27 | |
ART | On ARTa | 30 | 162 | 125–198 | 54 | 29–79 | 152 | 132–172 | 368 | 298–438 | |
STI | Screened | 30 | 2 | 2–3 | 5 | 3–6 | 11 | 10–12 | 18 | 16–21 | |
SRH | Provided CM | 23 | 15 | 13–18 | 7 | 2–12 | 73 | 66–80 | 95 | 72–117 | |
MSV | Provided post-GBV care | 29 | 13 | 10–17 | 6 | 1–11 | 71 | 56–86 | 90 | 69–110 | |
Malawi | HTS | Tested | 15 | 25 | 19–30 | 3 | 1–4 | 57 | 46–67 | 84 | 73–94 |
ART | On ARTa | 15 | 260 | 177–344 | 26 | 14–38 | 471 | 407–535 | 757 | 608–907 | |
STI | Screened | 15 | 9 | 7–10 | 2 | 1–2 | 30 | 27–34 | 41 | 37–44 | |
SRH | Provided CM | 11 | 31 | 27–35 | 1 | 1–2 | 75 | 66–85 | 108 | 70–145 | |
MSV | Provided post-GBV care | 15 | 305 | 242–367 | 2 | 1–3 | 933 | 897–969 | 1240 | 1156–1324 |